Medical Devices & Consumables
Global Tumor Excision Device Market Research Report 2026
- Jan 17, 26
- ID: 687610
- Pages: 140
- Figures: 143
- Views: 12
This report delivers a comprehensive overview of the global Tumor Excision Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Tumor Excision Device. The Tumor Excision Device market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Tumor Excision Device market comprehensively. Regional market sizes by Type, by Application, by Surgical Approach, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Tumor Excision Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Medtronic
J &J
B. Braun (Aesculap)
ConMed
Olympus
ERBE
LED SPA
Cooper Surgical
Karl Storz
KLS Martin
Soering
Utah Medical
Symmetry Surgical (Bovie)
Eschmann
Meyer-Haake
Ellman
IBBAB
Lamidey
Bowa
Union Medical
Shanghai Hutong
KINDY ELECTRONIC
Heal Force
Changzhou Yanling
Segment by Type
Electrosurgical Devices
Ultrasonic Devices
Laser Resection
Segment by Surgical Approach
Open Surgery
Laparoscopic/Thoracoscopic
Endoscopic
Segment by Cnacer Type
Solid Tumors
Hematologic
by Application
Hospitals
Cancer Centers
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Surgical Approach, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Tumor Excision Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Tumor Excision Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Tumor Excision Device market comprehensively. Regional market sizes by Type, by Application, by Surgical Approach, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Tumor Excision Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Medtronic
J &J
B. Braun (Aesculap)
ConMed
Olympus
ERBE
LED SPA
Cooper Surgical
Karl Storz
KLS Martin
Soering
Utah Medical
Symmetry Surgical (Bovie)
Eschmann
Meyer-Haake
Ellman
IBBAB
Lamidey
Bowa
Union Medical
Shanghai Hutong
KINDY ELECTRONIC
Heal Force
Changzhou Yanling
Segment by Type
Electrosurgical Devices
Ultrasonic Devices
Laser Resection
Segment by Surgical Approach
Open Surgery
Laparoscopic/Thoracoscopic
Endoscopic
Segment by Cnacer Type
Solid Tumors
Hematologic
by Application
Hospitals
Cancer Centers
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Surgical Approach, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Tumor Excision Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Tumor Excision Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Tumor Excision Device Market Overview
1.1 Product Definition
1.2 Tumor Excision Device by Type
1.2.1 Global Tumor Excision Device Market Value by Type: 2025 vs 2032
1.2.2 Electrosurgical Devices
1.2.3 Ultrasonic Devices
1.2.4 Laser Resection
1.3 Tumor Excision Device by Surgical Approach
1.3.1 Global Tumor Excision Device Market Value by Surgical Approach: 2025 vs 2032
1.3.2 Open Surgery
1.3.3 Laparoscopic/Thoracoscopic
1.3.4 Endoscopic
1.4 Tumor Excision Device by Cnacer Type
1.4.1 Global Tumor Excision Device Market Value by Cnacer Type: 2025 vs 2032
1.4.2 Solid Tumors
1.4.3 Hematologic
1.5 Tumor Excision Device by Application
1.5.1 Global Tumor Excision Device Market Value by Application: 2025 vs 2032
1.5.2 Hospitals
1.5.3 Cancer Centers
1.5.4 Other
1.6 Global Tumor Excision Device Market Size Estimates and Forecasts
1.6.1 Global Tumor Excision Device Revenue 2021–2032
1.6.2 Global Tumor Excision Device Sales 2021–2032
1.6.3 Global Tumor Excision Device Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Tumor Excision Device Market Competition by Manufacturers
2.1 Global Tumor Excision Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Tumor Excision Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Tumor Excision Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Tumor Excision Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Tumor Excision Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Tumor Excision Device, Product Types and Applications
2.7 Global Key Manufacturers of Tumor Excision Device, Date of Entry into the Industry
2.8 Global Tumor Excision Device Market Competitive Situation and Trends
2.8.1 Global Tumor Excision Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Tumor Excision Device Players Market Share by Revenue
2.8.3 Global Tumor Excision Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tumor Excision Device Market Scenario by Region
3.1 Global Tumor Excision Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Tumor Excision Device Sales by Region: 2021–2032
3.2.1 Global Tumor Excision Device Sales by Region: 2021–2026
3.2.2 Global Tumor Excision Device Sales by Region: 2027–2032
3.3 Global Tumor Excision Device Revenue by Region: 2021–2032
3.3.1 Global Tumor Excision Device Revenue by Region: 2021–2026
3.3.2 Global Tumor Excision Device Revenue by Region: 2027–2032
3.4 North America Tumor Excision Device Market Facts & Figures by Country
3.4.1 North America Tumor Excision Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Tumor Excision Device Sales by Country (2021–2032)
3.4.3 North America Tumor Excision Device Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tumor Excision Device Market Facts & Figures by Country
3.5.1 Europe Tumor Excision Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Tumor Excision Device Sales by Country (2021–2032)
3.5.3 Europe Tumor Excision Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Excision Device Market Facts & Figures by Region
3.6.1 Asia Pacific Tumor Excision Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Tumor Excision Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Tumor Excision Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tumor Excision Device Market Facts & Figures by Country
3.7.1 Latin America Tumor Excision Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Tumor Excision Device Sales by Country (2021–2032)
3.7.3 Latin America Tumor Excision Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tumor Excision Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Excision Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Tumor Excision Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Tumor Excision Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tumor Excision Device Sales by Type (2021–2032)
4.1.1 Global Tumor Excision Device Sales by Type (2021–2026)
4.1.2 Global Tumor Excision Device Sales by Type (2027–2032)
4.1.3 Global Tumor Excision Device Sales Market Share by Type (2021–2032)
4.2 Global Tumor Excision Device Revenue by Type (2021–2032)
4.2.1 Global Tumor Excision Device Revenue by Type (2021–2026)
4.2.2 Global Tumor Excision Device Revenue by Type (2027–2032)
4.2.3 Global Tumor Excision Device Revenue Market Share by Type (2021–2032)
4.3 Global Tumor Excision Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Tumor Excision Device Sales by Application (2021–2032)
5.1.1 Global Tumor Excision Device Sales by Application (2021–2026)
5.1.2 Global Tumor Excision Device Sales by Application (2027–2032)
5.1.3 Global Tumor Excision Device Sales Market Share by Application (2021–2032)
5.2 Global Tumor Excision Device Revenue by Application (2021–2032)
5.2.1 Global Tumor Excision Device Revenue by Application (2021–2026)
5.2.2 Global Tumor Excision Device Revenue by Application (2027–2032)
5.2.3 Global Tumor Excision Device Revenue Market Share by Application (2021–2032)
5.3 Global Tumor Excision Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Tumor Excision Device Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 J &J
6.2.1 J &J Company Information
6.2.2 J &J Description and Business Overview
6.2.3 J &J Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 J &J Tumor Excision Device Product Portfolio
6.2.5 J &J Recent Developments/Updates
6.3 B. Braun (Aesculap)
6.3.1 B. Braun (Aesculap) Company Information
6.3.2 B. Braun (Aesculap) Description and Business Overview
6.3.3 B. Braun (Aesculap) Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 B. Braun (Aesculap) Tumor Excision Device Product Portfolio
6.3.5 B. Braun (Aesculap) Recent Developments/Updates
6.4 ConMed
6.4.1 ConMed Company Information
6.4.2 ConMed Description and Business Overview
6.4.3 ConMed Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 ConMed Tumor Excision Device Product Portfolio
6.4.5 ConMed Recent Developments/Updates
6.5 Olympus
6.5.1 Olympus Company Information
6.5.2 Olympus Description and Business Overview
6.5.3 Olympus Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Olympus Tumor Excision Device Product Portfolio
6.5.5 Olympus Recent Developments/Updates
6.6 ERBE
6.6.1 ERBE Company Information
6.6.2 ERBE Description and Business Overview
6.6.3 ERBE Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 ERBE Tumor Excision Device Product Portfolio
6.6.5 ERBE Recent Developments/Updates
6.7 LED SPA
6.7.1 LED SPA Company Information
6.7.2 LED SPA Description and Business Overview
6.7.3 LED SPA Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 LED SPA Tumor Excision Device Product Portfolio
6.7.5 LED SPA Recent Developments/Updates
6.8 Cooper Surgical
6.8.1 Cooper Surgical Company Information
6.8.2 Cooper Surgical Description and Business Overview
6.8.3 Cooper Surgical Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Cooper Surgical Tumor Excision Device Product Portfolio
6.8.5 Cooper Surgical Recent Developments/Updates
6.9 Karl Storz
6.9.1 Karl Storz Company Information
6.9.2 Karl Storz Description and Business Overview
6.9.3 Karl Storz Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Karl Storz Tumor Excision Device Product Portfolio
6.9.5 Karl Storz Recent Developments/Updates
6.10 KLS Martin
6.10.1 KLS Martin Company Information
6.10.2 KLS Martin Description and Business Overview
6.10.3 KLS Martin Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 KLS Martin Tumor Excision Device Product Portfolio
6.10.5 KLS Martin Recent Developments/Updates
6.11 Soering
6.11.1 Soering Company Information
6.11.2 Soering Description and Business Overview
6.11.3 Soering Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Soering Tumor Excision Device Product Portfolio
6.11.5 Soering Recent Developments/Updates
6.12 Utah Medical
6.12.1 Utah Medical Company Information
6.12.2 Utah Medical Description and Business Overview
6.12.3 Utah Medical Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Utah Medical Tumor Excision Device Product Portfolio
6.12.5 Utah Medical Recent Developments/Updates
6.13 Symmetry Surgical (Bovie)
6.13.1 Symmetry Surgical (Bovie) Company Information
6.13.2 Symmetry Surgical (Bovie) Description and Business Overview
6.13.3 Symmetry Surgical (Bovie) Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Symmetry Surgical (Bovie) Tumor Excision Device Product Portfolio
6.13.5 Symmetry Surgical (Bovie) Recent Developments/Updates
6.14 Eschmann
6.14.1 Eschmann Company Information
6.14.2 Eschmann Description and Business Overview
6.14.3 Eschmann Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Eschmann Tumor Excision Device Product Portfolio
6.14.5 Eschmann Recent Developments/Updates
6.15 Meyer-Haake
6.15.1 Meyer-Haake Company Information
6.15.2 Meyer-Haake Description and Business Overview
6.15.3 Meyer-Haake Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Meyer-Haake Tumor Excision Device Product Portfolio
6.15.5 Meyer-Haake Recent Developments/Updates
6.16 Ellman
6.16.1 Ellman Company Information
6.16.2 Ellman Description and Business Overview
6.16.3 Ellman Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Ellman Tumor Excision Device Product Portfolio
6.16.5 Ellman Recent Developments/Updates
6.17 IBBAB
6.17.1 IBBAB Company Information
6.17.2 IBBAB Description and Business Overview
6.17.3 IBBAB Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 IBBAB Tumor Excision Device Product Portfolio
6.17.5 IBBAB Recent Developments/Updates
6.18 Lamidey
6.18.1 Lamidey Company Information
6.18.2 Lamidey Description and Business Overview
6.18.3 Lamidey Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Lamidey Tumor Excision Device Product Portfolio
6.18.5 Lamidey Recent Developments/Updates
6.19 Bowa
6.19.1 Bowa Company Information
6.19.2 Bowa Description and Business Overview
6.19.3 Bowa Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Bowa Tumor Excision Device Product Portfolio
6.19.5 Bowa Recent Developments/Updates
6.20 Union Medical
6.20.1 Union Medical Company Information
6.20.2 Union Medical Description and Business Overview
6.20.3 Union Medical Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Union Medical Tumor Excision Device Product Portfolio
6.20.5 Union Medical Recent Developments/Updates
6.21 Shanghai Hutong
6.21.1 Shanghai Hutong Company Information
6.21.2 Shanghai Hutong Description and Business Overview
6.21.3 Shanghai Hutong Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Shanghai Hutong Tumor Excision Device Product Portfolio
6.21.5 Shanghai Hutong Recent Developments/Updates
6.22 KINDY ELECTRONIC
6.22.1 KINDY ELECTRONIC Company Information
6.22.2 KINDY ELECTRONIC Description and Business Overview
6.22.3 KINDY ELECTRONIC Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 KINDY ELECTRONIC Tumor Excision Device Product Portfolio
6.22.5 KINDY ELECTRONIC Recent Developments/Updates
6.23 Heal Force
6.23.1 Heal Force Company Information
6.23.2 Heal Force Description and Business Overview
6.23.3 Heal Force Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Heal Force Tumor Excision Device Product Portfolio
6.23.5 Heal Force Recent Developments/Updates
6.24 Changzhou Yanling
6.24.1 Changzhou Yanling Company Information
6.24.2 Changzhou Yanling Description and Business Overview
6.24.3 Changzhou Yanling Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Changzhou Yanling Tumor Excision Device Product Portfolio
6.24.5 Changzhou Yanling Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Excision Device Industry Chain Analysis
7.2 Tumor Excision Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Excision Device Production Mode & Process Analysis
7.4 Tumor Excision Device Sales and Marketing
7.4.1 Tumor Excision Device Sales Channels
7.4.2 Tumor Excision Device Distributors
7.5 Tumor Excision Device Customer Analysis
8 Tumor Excision Device Market Dynamics
8.1 Tumor Excision Device Industry Trends
8.2 Tumor Excision Device Market Drivers
8.3 Tumor Excision Device Market Challenges
8.4 Tumor Excision Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Tumor Excision Device by Type
1.2.1 Global Tumor Excision Device Market Value by Type: 2025 vs 2032
1.2.2 Electrosurgical Devices
1.2.3 Ultrasonic Devices
1.2.4 Laser Resection
1.3 Tumor Excision Device by Surgical Approach
1.3.1 Global Tumor Excision Device Market Value by Surgical Approach: 2025 vs 2032
1.3.2 Open Surgery
1.3.3 Laparoscopic/Thoracoscopic
1.3.4 Endoscopic
1.4 Tumor Excision Device by Cnacer Type
1.4.1 Global Tumor Excision Device Market Value by Cnacer Type: 2025 vs 2032
1.4.2 Solid Tumors
1.4.3 Hematologic
1.5 Tumor Excision Device by Application
1.5.1 Global Tumor Excision Device Market Value by Application: 2025 vs 2032
1.5.2 Hospitals
1.5.3 Cancer Centers
1.5.4 Other
1.6 Global Tumor Excision Device Market Size Estimates and Forecasts
1.6.1 Global Tumor Excision Device Revenue 2021–2032
1.6.2 Global Tumor Excision Device Sales 2021–2032
1.6.3 Global Tumor Excision Device Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Tumor Excision Device Market Competition by Manufacturers
2.1 Global Tumor Excision Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Tumor Excision Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Tumor Excision Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Tumor Excision Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Tumor Excision Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Tumor Excision Device, Product Types and Applications
2.7 Global Key Manufacturers of Tumor Excision Device, Date of Entry into the Industry
2.8 Global Tumor Excision Device Market Competitive Situation and Trends
2.8.1 Global Tumor Excision Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Tumor Excision Device Players Market Share by Revenue
2.8.3 Global Tumor Excision Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tumor Excision Device Market Scenario by Region
3.1 Global Tumor Excision Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Tumor Excision Device Sales by Region: 2021–2032
3.2.1 Global Tumor Excision Device Sales by Region: 2021–2026
3.2.2 Global Tumor Excision Device Sales by Region: 2027–2032
3.3 Global Tumor Excision Device Revenue by Region: 2021–2032
3.3.1 Global Tumor Excision Device Revenue by Region: 2021–2026
3.3.2 Global Tumor Excision Device Revenue by Region: 2027–2032
3.4 North America Tumor Excision Device Market Facts & Figures by Country
3.4.1 North America Tumor Excision Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Tumor Excision Device Sales by Country (2021–2032)
3.4.3 North America Tumor Excision Device Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tumor Excision Device Market Facts & Figures by Country
3.5.1 Europe Tumor Excision Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Tumor Excision Device Sales by Country (2021–2032)
3.5.3 Europe Tumor Excision Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Excision Device Market Facts & Figures by Region
3.6.1 Asia Pacific Tumor Excision Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Tumor Excision Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Tumor Excision Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tumor Excision Device Market Facts & Figures by Country
3.7.1 Latin America Tumor Excision Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Tumor Excision Device Sales by Country (2021–2032)
3.7.3 Latin America Tumor Excision Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tumor Excision Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Excision Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Tumor Excision Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Tumor Excision Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tumor Excision Device Sales by Type (2021–2032)
4.1.1 Global Tumor Excision Device Sales by Type (2021–2026)
4.1.2 Global Tumor Excision Device Sales by Type (2027–2032)
4.1.3 Global Tumor Excision Device Sales Market Share by Type (2021–2032)
4.2 Global Tumor Excision Device Revenue by Type (2021–2032)
4.2.1 Global Tumor Excision Device Revenue by Type (2021–2026)
4.2.2 Global Tumor Excision Device Revenue by Type (2027–2032)
4.2.3 Global Tumor Excision Device Revenue Market Share by Type (2021–2032)
4.3 Global Tumor Excision Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Tumor Excision Device Sales by Application (2021–2032)
5.1.1 Global Tumor Excision Device Sales by Application (2021–2026)
5.1.2 Global Tumor Excision Device Sales by Application (2027–2032)
5.1.3 Global Tumor Excision Device Sales Market Share by Application (2021–2032)
5.2 Global Tumor Excision Device Revenue by Application (2021–2032)
5.2.1 Global Tumor Excision Device Revenue by Application (2021–2026)
5.2.2 Global Tumor Excision Device Revenue by Application (2027–2032)
5.2.3 Global Tumor Excision Device Revenue Market Share by Application (2021–2032)
5.3 Global Tumor Excision Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Tumor Excision Device Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 J &J
6.2.1 J &J Company Information
6.2.2 J &J Description and Business Overview
6.2.3 J &J Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 J &J Tumor Excision Device Product Portfolio
6.2.5 J &J Recent Developments/Updates
6.3 B. Braun (Aesculap)
6.3.1 B. Braun (Aesculap) Company Information
6.3.2 B. Braun (Aesculap) Description and Business Overview
6.3.3 B. Braun (Aesculap) Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 B. Braun (Aesculap) Tumor Excision Device Product Portfolio
6.3.5 B. Braun (Aesculap) Recent Developments/Updates
6.4 ConMed
6.4.1 ConMed Company Information
6.4.2 ConMed Description and Business Overview
6.4.3 ConMed Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 ConMed Tumor Excision Device Product Portfolio
6.4.5 ConMed Recent Developments/Updates
6.5 Olympus
6.5.1 Olympus Company Information
6.5.2 Olympus Description and Business Overview
6.5.3 Olympus Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Olympus Tumor Excision Device Product Portfolio
6.5.5 Olympus Recent Developments/Updates
6.6 ERBE
6.6.1 ERBE Company Information
6.6.2 ERBE Description and Business Overview
6.6.3 ERBE Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 ERBE Tumor Excision Device Product Portfolio
6.6.5 ERBE Recent Developments/Updates
6.7 LED SPA
6.7.1 LED SPA Company Information
6.7.2 LED SPA Description and Business Overview
6.7.3 LED SPA Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 LED SPA Tumor Excision Device Product Portfolio
6.7.5 LED SPA Recent Developments/Updates
6.8 Cooper Surgical
6.8.1 Cooper Surgical Company Information
6.8.2 Cooper Surgical Description and Business Overview
6.8.3 Cooper Surgical Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Cooper Surgical Tumor Excision Device Product Portfolio
6.8.5 Cooper Surgical Recent Developments/Updates
6.9 Karl Storz
6.9.1 Karl Storz Company Information
6.9.2 Karl Storz Description and Business Overview
6.9.3 Karl Storz Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Karl Storz Tumor Excision Device Product Portfolio
6.9.5 Karl Storz Recent Developments/Updates
6.10 KLS Martin
6.10.1 KLS Martin Company Information
6.10.2 KLS Martin Description and Business Overview
6.10.3 KLS Martin Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 KLS Martin Tumor Excision Device Product Portfolio
6.10.5 KLS Martin Recent Developments/Updates
6.11 Soering
6.11.1 Soering Company Information
6.11.2 Soering Description and Business Overview
6.11.3 Soering Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Soering Tumor Excision Device Product Portfolio
6.11.5 Soering Recent Developments/Updates
6.12 Utah Medical
6.12.1 Utah Medical Company Information
6.12.2 Utah Medical Description and Business Overview
6.12.3 Utah Medical Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Utah Medical Tumor Excision Device Product Portfolio
6.12.5 Utah Medical Recent Developments/Updates
6.13 Symmetry Surgical (Bovie)
6.13.1 Symmetry Surgical (Bovie) Company Information
6.13.2 Symmetry Surgical (Bovie) Description and Business Overview
6.13.3 Symmetry Surgical (Bovie) Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Symmetry Surgical (Bovie) Tumor Excision Device Product Portfolio
6.13.5 Symmetry Surgical (Bovie) Recent Developments/Updates
6.14 Eschmann
6.14.1 Eschmann Company Information
6.14.2 Eschmann Description and Business Overview
6.14.3 Eschmann Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Eschmann Tumor Excision Device Product Portfolio
6.14.5 Eschmann Recent Developments/Updates
6.15 Meyer-Haake
6.15.1 Meyer-Haake Company Information
6.15.2 Meyer-Haake Description and Business Overview
6.15.3 Meyer-Haake Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Meyer-Haake Tumor Excision Device Product Portfolio
6.15.5 Meyer-Haake Recent Developments/Updates
6.16 Ellman
6.16.1 Ellman Company Information
6.16.2 Ellman Description and Business Overview
6.16.3 Ellman Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Ellman Tumor Excision Device Product Portfolio
6.16.5 Ellman Recent Developments/Updates
6.17 IBBAB
6.17.1 IBBAB Company Information
6.17.2 IBBAB Description and Business Overview
6.17.3 IBBAB Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 IBBAB Tumor Excision Device Product Portfolio
6.17.5 IBBAB Recent Developments/Updates
6.18 Lamidey
6.18.1 Lamidey Company Information
6.18.2 Lamidey Description and Business Overview
6.18.3 Lamidey Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Lamidey Tumor Excision Device Product Portfolio
6.18.5 Lamidey Recent Developments/Updates
6.19 Bowa
6.19.1 Bowa Company Information
6.19.2 Bowa Description and Business Overview
6.19.3 Bowa Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Bowa Tumor Excision Device Product Portfolio
6.19.5 Bowa Recent Developments/Updates
6.20 Union Medical
6.20.1 Union Medical Company Information
6.20.2 Union Medical Description and Business Overview
6.20.3 Union Medical Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Union Medical Tumor Excision Device Product Portfolio
6.20.5 Union Medical Recent Developments/Updates
6.21 Shanghai Hutong
6.21.1 Shanghai Hutong Company Information
6.21.2 Shanghai Hutong Description and Business Overview
6.21.3 Shanghai Hutong Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Shanghai Hutong Tumor Excision Device Product Portfolio
6.21.5 Shanghai Hutong Recent Developments/Updates
6.22 KINDY ELECTRONIC
6.22.1 KINDY ELECTRONIC Company Information
6.22.2 KINDY ELECTRONIC Description and Business Overview
6.22.3 KINDY ELECTRONIC Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 KINDY ELECTRONIC Tumor Excision Device Product Portfolio
6.22.5 KINDY ELECTRONIC Recent Developments/Updates
6.23 Heal Force
6.23.1 Heal Force Company Information
6.23.2 Heal Force Description and Business Overview
6.23.3 Heal Force Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Heal Force Tumor Excision Device Product Portfolio
6.23.5 Heal Force Recent Developments/Updates
6.24 Changzhou Yanling
6.24.1 Changzhou Yanling Company Information
6.24.2 Changzhou Yanling Description and Business Overview
6.24.3 Changzhou Yanling Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Changzhou Yanling Tumor Excision Device Product Portfolio
6.24.5 Changzhou Yanling Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Excision Device Industry Chain Analysis
7.2 Tumor Excision Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Excision Device Production Mode & Process Analysis
7.4 Tumor Excision Device Sales and Marketing
7.4.1 Tumor Excision Device Sales Channels
7.4.2 Tumor Excision Device Distributors
7.5 Tumor Excision Device Customer Analysis
8 Tumor Excision Device Market Dynamics
8.1 Tumor Excision Device Industry Trends
8.2 Tumor Excision Device Market Drivers
8.3 Tumor Excision Device Market Challenges
8.4 Tumor Excision Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Tumor Excision Device Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Tumor Excision Device Market Value by Surgical Approach (US$ Million), 2025 vs 2032
Table 3. Global Tumor Excision Device Market Value by Cnacer Type (US$ Million), 2025 vs 2032
Table 4. Global Tumor Excision Device Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Tumor Excision Device Market Competitive Situation by Manufacturers in 2025
Table 6. Global Tumor Excision Device Sales (Units) of Key Manufacturers (2021–2026)
Table 7. Global Tumor Excision Device Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Tumor Excision Device Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Tumor Excision Device Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Tumor Excision Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Tumor Excision Device, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Tumor Excision Device, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Tumor Excision Device, Product Types and Applications
Table 14. Global Key Manufacturers of Tumor Excision Device, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Tumor Excision Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tumor Excision Device Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Tumor Excision Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Tumor Excision Device Sales by Region (Units), 2021–2026
Table 20. Global Tumor Excision Device Sales Market Share by Region (2021–2026)
Table 21. Global Tumor Excision Device Sales by Region (Units), 2027–2032
Table 22. Global Tumor Excision Device Sales Market Share by Region (2027–2032)
Table 23. Global Tumor Excision Device Revenue by Region (US$ Million), 2021–2026
Table 24. Global Tumor Excision Device Revenue Market Share by Region (2021–2026)
Table 25. Global Tumor Excision Device Revenue by Region (US$ Million), 2027–2032
Table 26. Global Tumor Excision Device Revenue Market Share by Region (2027–2032)
Table 27. North America Tumor Excision Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Tumor Excision Device Sales by Country (Units), 2021–2026
Table 29. North America Tumor Excision Device Sales by Country (Units), 2027–2032
Table 30. North America Tumor Excision Device Revenue by Country (US$ Million), 2021–2026
Table 31. North America Tumor Excision Device Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Tumor Excision Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Tumor Excision Device Sales by Country (Units), 2021–2026
Table 34. Europe Tumor Excision Device Sales by Country (Units), 2027–2032
Table 35. Europe Tumor Excision Device Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Tumor Excision Device Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Tumor Excision Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Tumor Excision Device Sales by Region (Units), 2021–2026
Table 39. Asia Pacific Tumor Excision Device Sales by Region (Units), 2027–2032
Table 40. Asia Pacific Tumor Excision Device Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Tumor Excision Device Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Tumor Excision Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Tumor Excision Device Sales by Country (Units), 2021–2026
Table 44. Latin America Tumor Excision Device Sales by Country (Units), 2027–2032
Table 45. Latin America Tumor Excision Device Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Tumor Excision Device Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Tumor Excision Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Tumor Excision Device Sales by Country (Units), 2021–2026
Table 49. Middle East and Africa Tumor Excision Device Sales by Country (Units), 2027–2032
Table 50. Middle East and Africa Tumor Excision Device Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Tumor Excision Device Revenue by Country (US$ Million), 2027–2032
Table 52. Global Tumor Excision Device Sales (Units) by Type (2021–2026)
Table 53. Global Tumor Excision Device Sales (Units) by Type (2027–2032)
Table 54. Global Tumor Excision Device Sales Market Share by Type (2021–2026)
Table 55. Global Tumor Excision Device Sales Market Share by Type (2027–2032)
Table 56. Global Tumor Excision Device Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Tumor Excision Device Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Tumor Excision Device Revenue Market Share by Type (2021–2026)
Table 59. Global Tumor Excision Device Revenue Market Share by Type (2027–2032)
Table 60. Global Tumor Excision Device Price (US$/Unit) by Type (2021–2026)
Table 61. Global Tumor Excision Device Price (US$/Unit) by Type (2027–2032)
Table 62. Global Tumor Excision Device Sales (Units) by Application (2021–2026)
Table 63. Global Tumor Excision Device Sales (Units) by Application (2027–2032)
Table 64. Global Tumor Excision Device Sales Market Share by Application (2021–2026)
Table 65. Global Tumor Excision Device Sales Market Share by Application (2027–2032)
Table 66. Global Tumor Excision Device Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Tumor Excision Device Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Tumor Excision Device Revenue Market Share by Application (2021–2026)
Table 69. Global Tumor Excision Device Revenue Market Share by Application (2027–2032)
Table 70. Global Tumor Excision Device Price (US$/Unit) by Application (2021–2026)
Table 71. Global Tumor Excision Device Price (US$/Unit) by Application (2027–2032)
Table 72. Medtronic Company Information
Table 73. Medtronic Description and Business Overview
Table 74. Medtronic Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Medtronic Tumor Excision Device Product
Table 76. Medtronic Recent Developments/Updates
Table 77. J &J Company Information
Table 78. J &J Description and Business Overview
Table 79. J &J Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. J &J Tumor Excision Device Product
Table 81. J &J Recent Developments/Updates
Table 82. B. Braun (Aesculap) Company Information
Table 83. B. Braun (Aesculap) Description and Business Overview
Table 84. B. Braun (Aesculap) Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. B. Braun (Aesculap) Tumor Excision Device Product
Table 86. B. Braun (Aesculap) Recent Developments/Updates
Table 87. ConMed Company Information
Table 88. ConMed Description and Business Overview
Table 89. ConMed Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. ConMed Tumor Excision Device Product
Table 91. ConMed Recent Developments/Updates
Table 92. Olympus Company Information
Table 93. Olympus Description and Business Overview
Table 94. Olympus Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Olympus Tumor Excision Device Product
Table 96. Olympus Recent Developments/Updates
Table 97. ERBE Company Information
Table 98. ERBE Description and Business Overview
Table 99. ERBE Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. ERBE Tumor Excision Device Product
Table 101. ERBE Recent Developments/Updates
Table 102. LED SPA Company Information
Table 103. LED SPA Description and Business Overview
Table 104. LED SPA Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. LED SPA Tumor Excision Device Product
Table 106. LED SPA Recent Developments/Updates
Table 107. Cooper Surgical Company Information
Table 108. Cooper Surgical Description and Business Overview
Table 109. Cooper Surgical Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. Cooper Surgical Tumor Excision Device Product
Table 111. Cooper Surgical Recent Developments/Updates
Table 112. Karl Storz Company Information
Table 113. Karl Storz Description and Business Overview
Table 114. Karl Storz Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Karl Storz Tumor Excision Device Product
Table 116. Karl Storz Recent Developments/Updates
Table 117. KLS Martin Company Information
Table 118. KLS Martin Description and Business Overview
Table 119. KLS Martin Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. KLS Martin Tumor Excision Device Product
Table 121. KLS Martin Recent Developments/Updates
Table 122. Soering Company Information
Table 123. Soering Description and Business Overview
Table 124. Soering Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Soering Tumor Excision Device Product
Table 126. Soering Recent Developments/Updates
Table 127. Utah Medical Company Information
Table 128. Utah Medical Description and Business Overview
Table 129. Utah Medical Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Utah Medical Tumor Excision Device Product
Table 131. Utah Medical Recent Developments/Updates
Table 132. Symmetry Surgical (Bovie) Company Information
Table 133. Symmetry Surgical (Bovie) Description and Business Overview
Table 134. Symmetry Surgical (Bovie) Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 135. Symmetry Surgical (Bovie) Tumor Excision Device Product
Table 136. Symmetry Surgical (Bovie) Recent Developments/Updates
Table 137. Eschmann Company Information
Table 138. Eschmann Description and Business Overview
Table 139. Eschmann Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 140. Eschmann Tumor Excision Device Product
Table 141. Eschmann Recent Developments/Updates
Table 142. Meyer-Haake Company Information
Table 143. Meyer-Haake Description and Business Overview
Table 144. Meyer-Haake Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 145. Meyer-Haake Tumor Excision Device Product
Table 146. Meyer-Haake Recent Developments/Updates
Table 147. Ellman Company Information
Table 148. Ellman Description and Business Overview
Table 149. Ellman Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 150. Ellman Tumor Excision Device Product
Table 151. Ellman Recent Developments/Updates
Table 152. IBBAB Company Information
Table 153. IBBAB Description and Business Overview
Table 154. IBBAB Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 155. IBBAB Tumor Excision Device Product
Table 156. IBBAB Recent Developments/Updates
Table 157. Lamidey Company Information
Table 158. Lamidey Description and Business Overview
Table 159. Lamidey Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 160. Lamidey Tumor Excision Device Product
Table 161. Lamidey Recent Developments/Updates
Table 162. Bowa Company Information
Table 163. Bowa Description and Business Overview
Table 164. Bowa Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 165. Bowa Tumor Excision Device Product
Table 166. Bowa Recent Developments/Updates
Table 167. Union Medical Company Information
Table 168. Union Medical Description and Business Overview
Table 169. Union Medical Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 170. Union Medical Tumor Excision Device Product
Table 171. Union Medical Recent Developments/Updates
Table 172. Shanghai Hutong Company Information
Table 173. Shanghai Hutong Description and Business Overview
Table 174. Shanghai Hutong Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 175. Shanghai Hutong Tumor Excision Device Product
Table 176. Shanghai Hutong Recent Developments/Updates
Table 177. KINDY ELECTRONIC Company Information
Table 178. KINDY ELECTRONIC Description and Business Overview
Table 179. KINDY ELECTRONIC Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 180. KINDY ELECTRONIC Tumor Excision Device Product
Table 181. KINDY ELECTRONIC Recent Developments/Updates
Table 182. Heal Force Company Information
Table 183. Heal Force Description and Business Overview
Table 184. Heal Force Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 185. Heal Force Tumor Excision Device Product
Table 186. Heal Force Recent Developments/Updates
Table 187. Changzhou Yanling Company Information
Table 188. Changzhou Yanling Description and Business Overview
Table 189. Changzhou Yanling Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 190. Changzhou Yanling Tumor Excision Device Product
Table 191. Changzhou Yanling Recent Developments/Updates
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Tumor Excision Device Distributors List
Table 195. Tumor Excision Device Customers List
Table 196. Tumor Excision Device Market Trends
Table 197. Tumor Excision Device Market Drivers
Table 198. Tumor Excision Device Market Challenges
Table 199. Tumor Excision Device Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
Table 203. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tumor Excision Device
Figure 2. Global Tumor Excision Device Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Tumor Excision Device Market Share by Type: 2025 & 2032
Figure 4. Electrosurgical Devices Product Picture
Figure 5. Ultrasonic Devices Product Picture
Figure 6. Laser Resection Product Picture
Figure 7. Global Tumor Excision Device Market Value by Surgical Approach (US$ Million), 2021–2032
Figure 8. Global Tumor Excision Device Market Share by Surgical Approach: 2025 vs 2032
Figure 9. Open Surgery Product Picture
Figure 10. Laparoscopic/Thoracoscopic Product Picture
Figure 11. Endoscopic Product Picture
Figure 12. Global Tumor Excision Device Market Value by Cnacer Type (US$ Million), 2021–2032
Figure 13. Global Tumor Excision Device Market Share by Cnacer Type: 2025 vs 2032
Figure 14. Solid Tumors Product Picture
Figure 15. Hematologic Product Picture
Figure 16. Global Tumor Excision Device Market Value by Application (US$ Million), 2021–2032
Figure 17. Global Tumor Excision Device Market Share by Application: 2025 & 2032
Figure 18. Hospitals
Figure 19. Cancer Centers
Figure 20. Other
Figure 21. Global Tumor Excision Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Tumor Excision Device Market Size (US$ Million), 2021–2032
Figure 23. Global Tumor Excision Device Sales (Units), 2021–2032
Figure 24. Global Tumor Excision Device Average Price (US$/Unit), 2021–2032
Figure 25. Tumor Excision Device Report Years Considered
Figure 26. Tumor Excision Device Sales Share by Manufacturers in 2025
Figure 27. Global Tumor Excision Device Revenue Share by Manufacturers in 2025
Figure 28. Top 5 and Top 10 Global Tumor Excision Device Players: Market Share by Revenue in Tumor Excision Device in 2025
Figure 29. Tumor Excision Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 30. Global Tumor Excision Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 31. North America Tumor Excision Device Sales Market Share by Country (2021–2032)
Figure 32. North America Tumor Excision Device Revenue Market Share by Country (2021–2032)
Figure 33. United States Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Canada Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Europe Tumor Excision Device Sales Market Share by Country (2021–2032)
Figure 36. Europe Tumor Excision Device Revenue Market Share by Country (2021–2032)
Figure 37. Germany Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. France Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. U.K. Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Italy Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Russia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Asia Pacific Tumor Excision Device Sales Market Share by Region (2021–2032)
Figure 43. Asia Pacific Tumor Excision Device Revenue Market Share by Region (2021–2032)
Figure 44. China Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Japan Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. South Korea Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. India Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Australia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. China Taiwan Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Southeast Asia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Latin America Tumor Excision Device Sales Market Share by Country (2021–2032)
Figure 52. Latin America Tumor Excision Device Revenue Market Share by Country (2021–2032)
Figure 53. Mexico Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Brazil Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Argentina Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Colombia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Middle East and Africa Tumor Excision Device Sales Market Share by Country (2021–2032)
Figure 58. Middle East and Africa Tumor Excision Device Revenue Market Share by Country (2021–2032)
Figure 59. Turkey Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Saudi Arabia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. UAE Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Global Sales Market Share of Tumor Excision Device by Type (2021–2032)
Figure 63. Global Revenue Market Share of Tumor Excision Device by Type (2021–2032)
Figure 64. Global Tumor Excision Device Price (US$/Unit) by Type (2021–2032)
Figure 65. Global Sales Market Share of Tumor Excision Device by Application (2021–2032)
Figure 66. Global Revenue Market Share of Tumor Excision Device by Application (2021–2032)
Figure 67. Global Tumor Excision Device Price (US$/Unit) by Application (2021–2032)
Figure 68. Tumor Excision Device Value Chain
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global Tumor Excision Device Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Tumor Excision Device Market Value by Surgical Approach (US$ Million), 2025 vs 2032
Table 3. Global Tumor Excision Device Market Value by Cnacer Type (US$ Million), 2025 vs 2032
Table 4. Global Tumor Excision Device Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Tumor Excision Device Market Competitive Situation by Manufacturers in 2025
Table 6. Global Tumor Excision Device Sales (Units) of Key Manufacturers (2021–2026)
Table 7. Global Tumor Excision Device Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Tumor Excision Device Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Tumor Excision Device Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Tumor Excision Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Tumor Excision Device, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Tumor Excision Device, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Tumor Excision Device, Product Types and Applications
Table 14. Global Key Manufacturers of Tumor Excision Device, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Tumor Excision Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tumor Excision Device Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Tumor Excision Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Tumor Excision Device Sales by Region (Units), 2021–2026
Table 20. Global Tumor Excision Device Sales Market Share by Region (2021–2026)
Table 21. Global Tumor Excision Device Sales by Region (Units), 2027–2032
Table 22. Global Tumor Excision Device Sales Market Share by Region (2027–2032)
Table 23. Global Tumor Excision Device Revenue by Region (US$ Million), 2021–2026
Table 24. Global Tumor Excision Device Revenue Market Share by Region (2021–2026)
Table 25. Global Tumor Excision Device Revenue by Region (US$ Million), 2027–2032
Table 26. Global Tumor Excision Device Revenue Market Share by Region (2027–2032)
Table 27. North America Tumor Excision Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Tumor Excision Device Sales by Country (Units), 2021–2026
Table 29. North America Tumor Excision Device Sales by Country (Units), 2027–2032
Table 30. North America Tumor Excision Device Revenue by Country (US$ Million), 2021–2026
Table 31. North America Tumor Excision Device Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Tumor Excision Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Tumor Excision Device Sales by Country (Units), 2021–2026
Table 34. Europe Tumor Excision Device Sales by Country (Units), 2027–2032
Table 35. Europe Tumor Excision Device Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Tumor Excision Device Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Tumor Excision Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Tumor Excision Device Sales by Region (Units), 2021–2026
Table 39. Asia Pacific Tumor Excision Device Sales by Region (Units), 2027–2032
Table 40. Asia Pacific Tumor Excision Device Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Tumor Excision Device Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Tumor Excision Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Tumor Excision Device Sales by Country (Units), 2021–2026
Table 44. Latin America Tumor Excision Device Sales by Country (Units), 2027–2032
Table 45. Latin America Tumor Excision Device Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Tumor Excision Device Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Tumor Excision Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Tumor Excision Device Sales by Country (Units), 2021–2026
Table 49. Middle East and Africa Tumor Excision Device Sales by Country (Units), 2027–2032
Table 50. Middle East and Africa Tumor Excision Device Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Tumor Excision Device Revenue by Country (US$ Million), 2027–2032
Table 52. Global Tumor Excision Device Sales (Units) by Type (2021–2026)
Table 53. Global Tumor Excision Device Sales (Units) by Type (2027–2032)
Table 54. Global Tumor Excision Device Sales Market Share by Type (2021–2026)
Table 55. Global Tumor Excision Device Sales Market Share by Type (2027–2032)
Table 56. Global Tumor Excision Device Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Tumor Excision Device Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Tumor Excision Device Revenue Market Share by Type (2021–2026)
Table 59. Global Tumor Excision Device Revenue Market Share by Type (2027–2032)
Table 60. Global Tumor Excision Device Price (US$/Unit) by Type (2021–2026)
Table 61. Global Tumor Excision Device Price (US$/Unit) by Type (2027–2032)
Table 62. Global Tumor Excision Device Sales (Units) by Application (2021–2026)
Table 63. Global Tumor Excision Device Sales (Units) by Application (2027–2032)
Table 64. Global Tumor Excision Device Sales Market Share by Application (2021–2026)
Table 65. Global Tumor Excision Device Sales Market Share by Application (2027–2032)
Table 66. Global Tumor Excision Device Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Tumor Excision Device Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Tumor Excision Device Revenue Market Share by Application (2021–2026)
Table 69. Global Tumor Excision Device Revenue Market Share by Application (2027–2032)
Table 70. Global Tumor Excision Device Price (US$/Unit) by Application (2021–2026)
Table 71. Global Tumor Excision Device Price (US$/Unit) by Application (2027–2032)
Table 72. Medtronic Company Information
Table 73. Medtronic Description and Business Overview
Table 74. Medtronic Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Medtronic Tumor Excision Device Product
Table 76. Medtronic Recent Developments/Updates
Table 77. J &J Company Information
Table 78. J &J Description and Business Overview
Table 79. J &J Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. J &J Tumor Excision Device Product
Table 81. J &J Recent Developments/Updates
Table 82. B. Braun (Aesculap) Company Information
Table 83. B. Braun (Aesculap) Description and Business Overview
Table 84. B. Braun (Aesculap) Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. B. Braun (Aesculap) Tumor Excision Device Product
Table 86. B. Braun (Aesculap) Recent Developments/Updates
Table 87. ConMed Company Information
Table 88. ConMed Description and Business Overview
Table 89. ConMed Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. ConMed Tumor Excision Device Product
Table 91. ConMed Recent Developments/Updates
Table 92. Olympus Company Information
Table 93. Olympus Description and Business Overview
Table 94. Olympus Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Olympus Tumor Excision Device Product
Table 96. Olympus Recent Developments/Updates
Table 97. ERBE Company Information
Table 98. ERBE Description and Business Overview
Table 99. ERBE Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. ERBE Tumor Excision Device Product
Table 101. ERBE Recent Developments/Updates
Table 102. LED SPA Company Information
Table 103. LED SPA Description and Business Overview
Table 104. LED SPA Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. LED SPA Tumor Excision Device Product
Table 106. LED SPA Recent Developments/Updates
Table 107. Cooper Surgical Company Information
Table 108. Cooper Surgical Description and Business Overview
Table 109. Cooper Surgical Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. Cooper Surgical Tumor Excision Device Product
Table 111. Cooper Surgical Recent Developments/Updates
Table 112. Karl Storz Company Information
Table 113. Karl Storz Description and Business Overview
Table 114. Karl Storz Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Karl Storz Tumor Excision Device Product
Table 116. Karl Storz Recent Developments/Updates
Table 117. KLS Martin Company Information
Table 118. KLS Martin Description and Business Overview
Table 119. KLS Martin Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. KLS Martin Tumor Excision Device Product
Table 121. KLS Martin Recent Developments/Updates
Table 122. Soering Company Information
Table 123. Soering Description and Business Overview
Table 124. Soering Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Soering Tumor Excision Device Product
Table 126. Soering Recent Developments/Updates
Table 127. Utah Medical Company Information
Table 128. Utah Medical Description and Business Overview
Table 129. Utah Medical Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Utah Medical Tumor Excision Device Product
Table 131. Utah Medical Recent Developments/Updates
Table 132. Symmetry Surgical (Bovie) Company Information
Table 133. Symmetry Surgical (Bovie) Description and Business Overview
Table 134. Symmetry Surgical (Bovie) Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 135. Symmetry Surgical (Bovie) Tumor Excision Device Product
Table 136. Symmetry Surgical (Bovie) Recent Developments/Updates
Table 137. Eschmann Company Information
Table 138. Eschmann Description and Business Overview
Table 139. Eschmann Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 140. Eschmann Tumor Excision Device Product
Table 141. Eschmann Recent Developments/Updates
Table 142. Meyer-Haake Company Information
Table 143. Meyer-Haake Description and Business Overview
Table 144. Meyer-Haake Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 145. Meyer-Haake Tumor Excision Device Product
Table 146. Meyer-Haake Recent Developments/Updates
Table 147. Ellman Company Information
Table 148. Ellman Description and Business Overview
Table 149. Ellman Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 150. Ellman Tumor Excision Device Product
Table 151. Ellman Recent Developments/Updates
Table 152. IBBAB Company Information
Table 153. IBBAB Description and Business Overview
Table 154. IBBAB Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 155. IBBAB Tumor Excision Device Product
Table 156. IBBAB Recent Developments/Updates
Table 157. Lamidey Company Information
Table 158. Lamidey Description and Business Overview
Table 159. Lamidey Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 160. Lamidey Tumor Excision Device Product
Table 161. Lamidey Recent Developments/Updates
Table 162. Bowa Company Information
Table 163. Bowa Description and Business Overview
Table 164. Bowa Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 165. Bowa Tumor Excision Device Product
Table 166. Bowa Recent Developments/Updates
Table 167. Union Medical Company Information
Table 168. Union Medical Description and Business Overview
Table 169. Union Medical Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 170. Union Medical Tumor Excision Device Product
Table 171. Union Medical Recent Developments/Updates
Table 172. Shanghai Hutong Company Information
Table 173. Shanghai Hutong Description and Business Overview
Table 174. Shanghai Hutong Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 175. Shanghai Hutong Tumor Excision Device Product
Table 176. Shanghai Hutong Recent Developments/Updates
Table 177. KINDY ELECTRONIC Company Information
Table 178. KINDY ELECTRONIC Description and Business Overview
Table 179. KINDY ELECTRONIC Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 180. KINDY ELECTRONIC Tumor Excision Device Product
Table 181. KINDY ELECTRONIC Recent Developments/Updates
Table 182. Heal Force Company Information
Table 183. Heal Force Description and Business Overview
Table 184. Heal Force Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 185. Heal Force Tumor Excision Device Product
Table 186. Heal Force Recent Developments/Updates
Table 187. Changzhou Yanling Company Information
Table 188. Changzhou Yanling Description and Business Overview
Table 189. Changzhou Yanling Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 190. Changzhou Yanling Tumor Excision Device Product
Table 191. Changzhou Yanling Recent Developments/Updates
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Tumor Excision Device Distributors List
Table 195. Tumor Excision Device Customers List
Table 196. Tumor Excision Device Market Trends
Table 197. Tumor Excision Device Market Drivers
Table 198. Tumor Excision Device Market Challenges
Table 199. Tumor Excision Device Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
Table 203. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tumor Excision Device
Figure 2. Global Tumor Excision Device Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Tumor Excision Device Market Share by Type: 2025 & 2032
Figure 4. Electrosurgical Devices Product Picture
Figure 5. Ultrasonic Devices Product Picture
Figure 6. Laser Resection Product Picture
Figure 7. Global Tumor Excision Device Market Value by Surgical Approach (US$ Million), 2021–2032
Figure 8. Global Tumor Excision Device Market Share by Surgical Approach: 2025 vs 2032
Figure 9. Open Surgery Product Picture
Figure 10. Laparoscopic/Thoracoscopic Product Picture
Figure 11. Endoscopic Product Picture
Figure 12. Global Tumor Excision Device Market Value by Cnacer Type (US$ Million), 2021–2032
Figure 13. Global Tumor Excision Device Market Share by Cnacer Type: 2025 vs 2032
Figure 14. Solid Tumors Product Picture
Figure 15. Hematologic Product Picture
Figure 16. Global Tumor Excision Device Market Value by Application (US$ Million), 2021–2032
Figure 17. Global Tumor Excision Device Market Share by Application: 2025 & 2032
Figure 18. Hospitals
Figure 19. Cancer Centers
Figure 20. Other
Figure 21. Global Tumor Excision Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Tumor Excision Device Market Size (US$ Million), 2021–2032
Figure 23. Global Tumor Excision Device Sales (Units), 2021–2032
Figure 24. Global Tumor Excision Device Average Price (US$/Unit), 2021–2032
Figure 25. Tumor Excision Device Report Years Considered
Figure 26. Tumor Excision Device Sales Share by Manufacturers in 2025
Figure 27. Global Tumor Excision Device Revenue Share by Manufacturers in 2025
Figure 28. Top 5 and Top 10 Global Tumor Excision Device Players: Market Share by Revenue in Tumor Excision Device in 2025
Figure 29. Tumor Excision Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 30. Global Tumor Excision Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 31. North America Tumor Excision Device Sales Market Share by Country (2021–2032)
Figure 32. North America Tumor Excision Device Revenue Market Share by Country (2021–2032)
Figure 33. United States Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Canada Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Europe Tumor Excision Device Sales Market Share by Country (2021–2032)
Figure 36. Europe Tumor Excision Device Revenue Market Share by Country (2021–2032)
Figure 37. Germany Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. France Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. U.K. Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Italy Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Russia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Asia Pacific Tumor Excision Device Sales Market Share by Region (2021–2032)
Figure 43. Asia Pacific Tumor Excision Device Revenue Market Share by Region (2021–2032)
Figure 44. China Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Japan Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. South Korea Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. India Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Australia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. China Taiwan Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Southeast Asia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Latin America Tumor Excision Device Sales Market Share by Country (2021–2032)
Figure 52. Latin America Tumor Excision Device Revenue Market Share by Country (2021–2032)
Figure 53. Mexico Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Brazil Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Argentina Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Colombia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Middle East and Africa Tumor Excision Device Sales Market Share by Country (2021–2032)
Figure 58. Middle East and Africa Tumor Excision Device Revenue Market Share by Country (2021–2032)
Figure 59. Turkey Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Saudi Arabia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. UAE Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Global Sales Market Share of Tumor Excision Device by Type (2021–2032)
Figure 63. Global Revenue Market Share of Tumor Excision Device by Type (2021–2032)
Figure 64. Global Tumor Excision Device Price (US$/Unit) by Type (2021–2032)
Figure 65. Global Sales Market Share of Tumor Excision Device by Application (2021–2032)
Figure 66. Global Revenue Market Share of Tumor Excision Device by Application (2021–2032)
Figure 67. Global Tumor Excision Device Price (US$/Unit) by Application (2021–2032)
Figure 68. Tumor Excision Device Value Chain
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232